Higher MDMX expression was associated with hypomethylating agent resistance and inferior survival in MDS patients, inferring it a potential therapeutic target.
Yu-Hung WangChien-Chin LinKristian GurashiBettina WingelhoferFabio M R AmaralChi-Yuan YaoHsin Ting HsiehMing Chih LiuHsin-An HouWen-Chien ChouKiran BattaDaniel H WisemanHwei-Fang TienPublished in: Leukemia (2023)